Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at www.RDInvesting.com and get exclusive access to our numerous stock reports and market updates.

Accenture Plc (NYSE: ACN) shares increased 0.75 percent to close at $73.53 a share Friday. The stock traded between $73.03 and $73.90 on volume of 3.20 million shares traded. Analysts at Robert W. Baird have recently upgraded the company?s rating to ?outperform? from ?neutral?. Shares of Accenture have gained approximately 10.0 percent year-to-date.

Find out more about Accenture including full access to the free equity report at:
www.RDInvesting.com/ACN

Amedisys Inc. (NASDAQ: AMED) shares increased 22.44 percent to close at $17.90 a share Friday. The stock traded between $15.85 and $18.70 on volume of 3.51 million shares traded. Analysts at CRT Capital have recently upgraded the company?s rating to ?fair value? from ?sell?. Shares of Amedisys have gained approximately 58.0 percent year-to-date.

Find out more about Amedisys including full access to the free equity report at:
www.RDInvesting.com/AMED

EnerSys (NYSE: ENS) shares increased 2.33 percent to close at $54.42 a share Friday. The stock traded between $52.81 and $54.80 on volume of 259,627 shares traded. Analysts at Ardour Capital have recently upgraded the company?s rating to ?accumulate? from ?reduce?. Shares of EnerSys have gained approximately 45.0 percent year-to-date.

Find out more about EnerSys including full access to the free equity report at:
www.RDInvesting.com/ENS

ESCO Technologies Inc. (NYSE: ESE) shares declined 3.76 percent to close at $32.72 a share Friday. The stock traded between $31.31 and $33.80 on volume of 170,246 shares traded. Analysts at Needham have recently downgraded the company?s rating to ?hold? from ?buy?. Shares of ESCO Technologies have fallen approximately 12.5 percent year-to-date.

Find out more about ESCO Technologies including full access to the free equity report at:
www.RDInvesting.com/ESE

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Research Driven Investing has no financial relationship with any company whose stock is mentioned in this release.

Contact:
Research Driven Investing
info@rdinvesting.com